There is no pinned content in this Editor's Picks module.
Click here to learn more about content pinning.
To access the replay, please dial (855) 859-2056 U.S./Canada or (404) 537-3406 International and enter passcode 48802750. An archived webcast will also be available for two weeks after the call on the Idenix website. Idenix Pharmaceuticals, Inc. ,...
Despite the current situation, our team continues to identify high momentum situations with growth potential -- there remains strong opportunity within careful discretion. Equity Leader has decided to cover Idenix Pharmaceuticals, Inc. for its current...
The top after-market NASDAQ gainers losers: Neurocrine Biosciences, Smith Micro Software, FriendFinder Networks and Dunkin' Brands Group. Energy XXI (Bermuda) Ltd. (EXXI) stock surged 4.39 percent to $39.25 in aftermarket trading session. The company...
They set an “equal weight” rating on the stock. Separately, analysts at William Blair reiterated an “outperform” rating on shares of Idenix Pharmaceuticals in a research note to investors on Friday, February 3rd. Analysts at Brean Murray Carret & Co....
Please log in approximately 5-10 minutes before each event to ensure a timely connection. The archived replay will be available on the Idenix website for two weeks following the conferences. Idenix Pharmaceuticals, Inc. , headquartered in Cambridge,...
A copy of this report featuring Inhibitex, Inc. (NASDAQ: INHX) is available at: www.BollingerReport.com/index.php?sm1=INHX. Bollinger Report is featuring Idenix Pharmaceuticals, Inc. for its changing role within the healthcare industry. Idenix...
There are no results for this module. Edit this module to change the search term used to query Wikipedia
There are no results for this module. Edit the module to change the search term used to query related articles.
There are no results for this module. Edit the module to change the search term used to query related quotes.
We found no quotes related to Idenix Pharmaceuticals, Inc..
